Poison Prevention Packaging Requirements: Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More than 80 mg of the Drug

TitlePoison Prevention Packaging Requirements: Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More than 80 mg of the Drug
ToC Doc Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More than 80 mg of the Drug
Docket Number2024-07651
Type Rule
Subject Poison Prevention Packaging Requirements:
Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More than 80 mg of the Drug
Publication Date2024-04-19
Last Updated Date 2024-04-18 08:15:09 -0400
Last Public Inspection2024-04-18
Filed At2024-04-18T08:45:00.000-04:00
PDF 2024-07651_PI.pdf (142260 bytes)
Download TXT / HTML / JSON
Number of Pages 11
Filing Typeregular
AgenciesConsumer Product Safety Commission

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021